BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8608659)

  • 1. Beta 2-microglobulin amyloidosis: why and how to look for it.
    Schaeffer J; Ehlerding G; Flöge J; Koch KM; Shaldon S
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S3-9. PubMed ID: 8608659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
    Czyz W; Szepietowski T
    Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenetic and diagnostic aspects of dialysis-related amyloidosis.
    Schaeffer J; Floege J; Ehlerding G; Koch KM
    Nephrol Dial Transplant; 1995; 10 Suppl 3():4-8. PubMed ID: 7494614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialysis related amyloidosis: a disease of chronic retention and inflammation?
    Floege J; Schäffer J; Koch KM; Shaldon S
    Kidney Int Suppl; 1992 Oct; 38():S78-85. PubMed ID: 1405384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodialysis-associated beta 2M amyloidosis: current controversies.
    Stein G; Sperschneider H; Fünfstück R; Ritz E
    Nephrol Dial Transplant; 1994; 9 Suppl 3():48-50. PubMed ID: 8072726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialysis-related amyloidosis: late finding or hidden epidemic?
    Dember LM; Jaber BL
    Semin Dial; 2006; 19(2):105-9. PubMed ID: 16551286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
    Gejyo F; Homma N; Arakawa M
    Kidney Int Suppl; 1993 Jun; 41():S78-82. PubMed ID: 8320951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.
    Saito A; Gejyo F
    Ther Apher Dial; 2006 Aug; 10(4):316-20. PubMed ID: 16911183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
    Kopeć J
    Przegl Lek; 2006; 63(7):567-72. PubMed ID: 17203811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-2-microglobulin-associated amyloidosis.
    Floege J; Ehlerding G
    Nephron; 1996; 72(1):9-26. PubMed ID: 8903856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extraskeletal problems and amyloid.
    Drüeke TB
    Kidney Int Suppl; 1999 Dec; 73():S89-93. PubMed ID: 10633472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of and therapy for patients with dialysis amyloidosis].
    Homma N; Gejyo F
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():348-52. PubMed ID: 15250322
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis and therapy for beta2-microglobulin amyloidosis in the K/DOQI guideline].
    Higuchi N; Maruyama H
    Clin Calcium; 2004 May; 14(5):744-9. PubMed ID: 15577036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of dialysis amyloidosis].
    Gejyo F; Hasegawa S; Homma N; Maruyama H; Maruyama S; Arakawa M
    Nihon Rinsho; 1992 Jan; 50 Suppl():796-800. PubMed ID: 1578769
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of haemodialysis membranes on beta 2-microglobulin kinetics: in vivo and in vitro studies.
    Zingraff J; Beyne P; Ureña P; Uzan M; Nguyen Khoa Man ; Descamps-Latscha B; Drüeke T
    Nephrol Dial Transplant; 1988; 3(3):284-90. PubMed ID: 3140102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoarticular disorders of renal origin: disease-related and iatrogenic.
    Kay J; Bardin T
    Baillieres Best Pract Res Clin Rheumatol; 2000 Jun; 14(2):285-305. PubMed ID: 10925746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta 2-microglobulin elimination in end-stage renal disease patients on renal replacement therapy.
    Stefanović V; Kostić S; Djordjević V; Mitić M; Bogicević M
    Perit Dial Int; 1993; 13 Suppl 2():S520-2. PubMed ID: 8399654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis.
    Iida Y; Miyata T; Inagi R; Sugiyama S; Maeda K
    Biochem Biophys Res Commun; 1994 Jun; 201(3):1235-41. PubMed ID: 8024566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysis-related amyloidosis.
    Manske CL
    J Lab Clin Med; 1994 Apr; 123(4):458-60. PubMed ID: 8144992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.